AXOGEN INC (AXGN) — insider trading
Health Care · NASDAQ
AXOGEN INC (AXGN) has 17 reported SEC Form 4 insider transactions in our data (latest 2026-06-24).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-24 | Wendell Amy McBride | Director | Grant / award / vesting (derivative) | 4,392 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Weiler Kathy Johnson | Director | Grant / award / vesting (derivative) | 4,392 | $0.00 | $0 | Form 4 |
| 2026-06-24 | TYNDALL JOSEPH A. | Director | Grant / award / vesting (derivative) | 4,392 | $0.00 | $0 | Form 4 |
| 2026-06-24 | THOMAS PAUL | Director | Grant / award / vesting (derivative) | 5,579 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Levine Alan M | Director | Grant / award / vesting (derivative) | 4,392 | $0.00 | $0 | Form 4 |
| 2026-06-24 | JOHNSON JOHN | Director | Grant / award / vesting (derivative) | 4,392 | $0.00 | $0 | Form 4 |
| 2026-06-24 | Burke William P. Mr. | Director | Grant / award / vesting (derivative) | 4,392 | $0.00 | $0 | Form 4 |
| 2026-06-19 | TYNDALL JOSEPH A. | Director | Option exercise / conversion (derivative) | 14,150 | $0.00 | $0 | Form 4 |
| 2026-06-19 | TYNDALL JOSEPH A. | Director | Option exercise / conversion | 14,150 | $0.00 | $0 | Form 4 |
| 2026-06-19 | THOMAS PAUL | Director | Option exercise / conversion (derivative) | 18,867 | $0.00 | $0 | Form 4 |
| 2026-06-19 | THOMAS PAUL | Director | Option exercise / conversion | 18,867 | $0.00 | $0 | Form 4 |
| 2026-06-19 | Wendell Amy McBride | Director | Option exercise / conversion (derivative) | 14,150 | $0.00 | $0 | Form 4 |
| 2026-06-19 | Wendell Amy McBride | Director | Option exercise / conversion | 14,150 | $0.00 | $0 | Form 4 |
| 2026-06-19 | Weiler Kathy Johnson | Director | Option exercise / conversion (derivative) | 14,150 | $0.00 | $0 | Form 4 |
| 2026-06-19 | Weiler Kathy Johnson | Director | Option exercise / conversion | 14,150 | $0.00 | $0 | Form 4 |
| 2026-06-19 | Levine Alan M | Director | Option exercise / conversion (derivative) | 14,150 | $0.00 | $0 | Form 4 |
| 2026-06-19 | Levine Alan M | Director | Option exercise / conversion | 14,150 | $0.00 | $0 | Form 4 |
Ask the chat about AXGN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AXOGEN INC (AXGN).
Last updated 2026-06-24 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.